Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Suspicious

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 09, 2022 6:00pm

217 Views

Post# 34668711

RE:Suspicious

So no one else here finds it unusual that the share price is obviously being held in a range? No concerns that this long awaited deal might dilute our shares? Injection of pharma capital in exchange for Sernova shares @ 1.40ish? Based on the trading, this is what I'm predicting. No such thing as a free lunch.

BioTeck wrote: So the price is clearly being held at the 1.40 range. Given the conditions of the market and Sernova's history, we should have been back to the Canaccord PP price by now. The fact we haven't makes me suspicious. Usually this means an upcoming PP but i don't think the management is even dumb enough to do that now. Then again, no one expected the Canaccord "deal" either.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle